Clinical Trial Update: The TRUST Study - CardioVascular Imaging IMT [Phase 4]

View source ↗

Summary

The TRUST study, a Phase 4 trial evaluating CardioVascular Imaging IMT, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Heart Failure
• Hyperthyroidism
• Hypothyroidism

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Thyroid Dysfunction, Atherosclerosis | Phase 4 | Status: COMPLETED